CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and neurotrauma, announced today that the trading symbol for its stock, trading on the OTC Bulletin Board, has been changed from ‘NVIV.OB’ to ‘NVIV’.